Inventor · disambiguated record
Susanta Sekhar Adhikari
Also filed as: ADHIKARI SUSANTA SEKHAR
10 granted patents·84 citations·filing 1999–2012
86Inventor score
Files withMILLENNIUM PHARM INC4ISIS PHARMACEUTICALS INC2SWAYZE ERIC E2BANDYOPADHYAY UDAY1MILLENIUM PHARMACEUTICALS INC1
Top patents by PatentIndex Score
10 records- 0193US7893039B2Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituentsISIS PHARMACEUTICALS INC·Filed 2008·Granted Feb 22, 2011·42 cites·16 claims
- 0292US8114856B2Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituentsSWAYZE ERIC E·Filed 2011·Granted Feb 14, 2012·22 cites·20 claims
- 0387US7943749B2Antimicrobial 2-deoxystreptamine compoundsISIS PHARMACEUTICALS INC·Filed 2007·Granted May 17, 2011·14 cites·23 claims
- 0482US8569264B2Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituentsSWAYZE ERIC E·Filed 2012·Granted Oct 29, 2013·5 cites·25 claims
- 0551US8901317B2Tryptamine derivatives, their preparation and their use in gastropathyBANDYOPADHYAY UDAY·Filed 2011·Granted Dec 2, 2014·1 cites·17 claims
- 0646US6433197B1Substituted oxygen alicyclic compounds, including methods for synthesis thereofMILLENNIUM PHARM INC·Filed 2001·Granted Aug 13, 2002·0 cites·53 claims
- 0745US6566538B1Substituted oxygen alicyclic compounds, including methods for synthesis thereofMILLENNIUM PHARM INC·Filed 2002·Granted May 20, 2003·0 cites·8 claims
- 0843US6541647B2Methods of synthesis of substituted tetrahydrofuran compoundMILLENNIUM PHARM INC·Filed 2001·Granted Apr 1, 2003·0 cites·18 claims
- 0929US6310221B1Methods for synthesis of substituted tetrahydrofuran compoundMILLENNIUM PHARM INC·Filed 1999·Granted Oct 30, 2001·0 cites·68 claims
- 1026US6306895B1Substituted oxygen alicyclic compounds, including methods for synthesis thereofMILLENIUM PHARMACEUTICALS INC·Filed 1999·Granted Oct 23, 2001·0 cites·76 claims
Join the waitlist — get patent alerts
Get an alert when Susanta Sekhar Adhikari files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →